ARCHIVES

Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum

This article is from The Cancer Letter archive.

Vol. 19 No. 02 | January 8, 1993

Download PDF Visit The Full Archive

Related Articles

Rauscher “Identifies” Four More Comprehensive Centers

June 21, 1974

Klausner Reaffirms NCI’s “No. 1 Priority” Is Funding investigator-Initiated Research

September 13, 1996

Pitt Seeks Biostatistician For NSABP, Hearing Delayed a Week

September 23, 1994

NIH Funding Opportunities Listed

March 13, 2009

Basic Biology Progress, Improved Survival Since 1971 Described By DeVita At Senate Hearing

February 27, 1981

This month’s 8-page Business & Regulatory Report included in this issue.

January 30, 2004